Exciting News! 3D Bio-Tissues (3DBT), a BSF Enterprise PLC subsidiary, has been awarded the prestigious ๐ก๐ผ๐ฟ๐๐ต๐ฒ๐ฟ๐ป ๐๐ฐ๐ฐ๐ฒ๐น๐ฒ๐ฟ๐ฎ๐๐ผ๐ฟ ๐๐ฟ๐ผ๐๐๐ต ๐ฆ๐๐ฝ๐ฝ๐ผ๐ฟ๐ ๐๐ฟ๐ฎ๐ป๐ ๐ผ๐ณ ยฃ๐ฑ๐ฌ,๐ฌ๐ฌ๐ฌ. This grant will accelerate the transition of ๐ฏ๐๐๐งโ๐ ๐ด๐ฟ๐ผ๐๐ป๐ฑ๐ฏ๐ฟ๐ฒ๐ฎ๐ธ๐ถ๐ป๐ด ๐น๐ฎ๐ฏ-๐ด๐ฟ๐ผ๐๐ป ๐น๐ฒ๐ฎ๐๐ต๐ฒ๐ฟ ๐๐ฒ๐ฐ๐ต๐ป๐ผ๐น๐ผ๐ด๐ from lab-scale development to small-scale manufacturing, a critical step towards commercialisation.
3DBTโs sustainable, scaffold-free tissue engineering innovation offers scalability and environmental benefits that position it as a ๐ด๐ฎ๐บ๐ฒ-๐ฐ๐ต๐ฎ๐ป๐ด๐ฒ๐ฟ in the $32.26 billion leather market, projected to grow to $47.89 billion by 2031.
Dr Che Connon, CEO and Founder of 3DBT, commented: โThis grant award is a pivotal moment for 3DBT. It enables us to accelerate the commercialisation of our lab-grown leather technology and underscores the growing recognition of its transformative potential.โ
Read the full announcement here:
